Kurt Fernstrom
Examiner (ID: 5518, Phone: (571)272-4422 , Office: P/3711 )
Most Active Art Unit | 3711 |
Art Unit(s) | 3714, 3712, 3715, 3711 |
Total Applications | 2669 |
Issued Applications | 1756 |
Pending Applications | 157 |
Abandoned Applications | 755 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6351681
[patent_doc_number] => 20100021933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'CELLOMICS SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 12/471853
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 136
[patent_figures_cnt] => 136
[patent_no_of_words] => 148451
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021933.pdf
[firstpage_image] =>[orig_patent_app_number] => 12471853
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/471853 | CELLOMICS SYSTEMS | May 25, 2009 | Abandoned |
Array
(
[id] => 6549714
[patent_doc_number] => 20100016569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'CELLOMICS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/472010
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 137
[patent_figures_cnt] => 137
[patent_no_of_words] => 148451
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016569.pdf
[firstpage_image] =>[orig_patent_app_number] => 12472010
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/472010 | CELLOMICS SYSTEM | May 25, 2009 | Abandoned |
Array
(
[id] => 6549693
[patent_doc_number] => 20100016568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'CELLOMICS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/471947
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 137
[patent_figures_cnt] => 137
[patent_no_of_words] => 148450
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016568.pdf
[firstpage_image] =>[orig_patent_app_number] => 12471947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/471947 | CELLOMICS SYSTEM | May 25, 2009 | Abandoned |
Array
(
[id] => 5465015
[patent_doc_number] => 20090325215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'CELLOMICS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/472037
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 137
[patent_figures_cnt] => 137
[patent_no_of_words] => 148480
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325215.pdf
[firstpage_image] =>[orig_patent_app_number] => 12472037
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/472037 | CELLOMICS SYSTEM | May 25, 2009 | Abandoned |
Array
(
[id] => 6333793
[patent_doc_number] => 20100018862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'CELLOMICS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/471993
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 137
[patent_figures_cnt] => 137
[patent_no_of_words] => 148451
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20100018862.pdf
[firstpage_image] =>[orig_patent_app_number] => 12471993
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/471993 | CELLOMICS SYSTEM | May 25, 2009 | Abandoned |
Array
(
[id] => 6083566
[patent_doc_number] => 20110144003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'MAINTENANCE THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE'
[patent_app_type] => utility
[patent_app_number] => 12/993170
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11649
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144003.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993170
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993170 | Maintenance therapy regime/regimen for the treatment of acne | May 19, 2009 | Issued |
Array
(
[id] => 6015002
[patent_doc_number] => 20110223242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'NANOPARTICLES CONTAINING A PEPTIDE, VECTORS CONTAINING SAID NANOPARTICLES, AND PHARMACEUTICAL USES OF SAID NANOPARTICLES AND VECTORS'
[patent_app_type] => utility
[patent_app_number] => 12/993664
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7660
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223242.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993664
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993664 | Nanoparticles containing a peptide, vectors containing said nanoparticles, and pharmaceutical uses of said nanoparticles and vectors | May 19, 2009 | Issued |
Array
(
[id] => 6118674
[patent_doc_number] => 20110076347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'Molecules Interfering with Binding of Calbindin to Inositol Monophosphatase for the Treatment of Mood Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/991700
[patent_app_country] => US
[patent_app_date] => 2009-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4570
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20110076347.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991700
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991700 | Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders | May 13, 2009 | Issued |
Array
(
[id] => 6127686
[patent_doc_number] => 20110086807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'FIBROMODULIN FORMULATION FOR REDUCING CORNEAL SCARRING'
[patent_app_type] => utility
[patent_app_number] => 12/937324
[patent_app_country] => US
[patent_app_date] => 2009-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7972
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086807.pdf
[firstpage_image] =>[orig_patent_app_number] => 12937324
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937324 | Fibromodulin formulation for reducing corneal scarring | Apr 30, 2009 | Issued |
Array
(
[id] => 5959519
[patent_doc_number] => 20110183906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'FACTOR IX CONJUGATES WITH EXTENDED HALF-LIVES'
[patent_app_type] => utility
[patent_app_number] => 12/989555
[patent_app_country] => US
[patent_app_date] => 2009-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8822
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183906.pdf
[firstpage_image] =>[orig_patent_app_number] => 12989555
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/989555 | FACTOR IX CONJUGATES WITH EXTENDED HALF-LIVES | Apr 23, 2009 | Abandoned |
Array
(
[id] => 5485718
[patent_doc_number] => 20090275483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'QUANTITATIVE MICROARRAY OF INTACT GLYCOLIPID CD1D INTERACTION AND CORRELATION WITH CELL-BASED CYTOKINE PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/423728
[patent_app_country] => US
[patent_app_date] => 2009-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6467
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275483.pdf
[firstpage_image] =>[orig_patent_app_number] => 12423728
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/423728 | Quantitative microarray of intact glycolipid CD1d interaction and correlation with cell-based cytokine production | Apr 13, 2009 | Issued |
Array
(
[id] => 10077509
[patent_doc_number] => 09115352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-25
[patent_title] => 'Method for the preparation of a nucleic acid library'
[patent_app_type] => utility
[patent_app_number] => 12/414174
[patent_app_country] => US
[patent_app_date] => 2009-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 8
[patent_no_of_words] => 24937
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 876
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12414174
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/414174 | Method for the preparation of a nucleic acid library | Mar 29, 2009 | Issued |
Array
(
[id] => 5473721
[patent_doc_number] => 20090246887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Diamond Crystallites For Biotechnological Applications'
[patent_app_type] => utility
[patent_app_number] => 12/411241
[patent_app_country] => US
[patent_app_date] => 2009-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4348
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246887.pdf
[firstpage_image] =>[orig_patent_app_number] => 12411241
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/411241 | Diamond Crystallites For Biotechnological Applications | Mar 24, 2009 | Abandoned |
Array
(
[id] => 6145043
[patent_doc_number] => 20110130472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'PROTEOSE PEPTONE FRACTION'
[patent_app_type] => utility
[patent_app_number] => 12/918523
[patent_app_country] => US
[patent_app_date] => 2009-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5840
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130472.pdf
[firstpage_image] =>[orig_patent_app_number] => 12918523
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918523 | PROTEOSE PEPTONE FRACTION | Feb 17, 2009 | Abandoned |
Array
(
[id] => 6120759
[patent_doc_number] => 20110077189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'COMPOSITION FOR STIMULATING NATURAL KILLER CELL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/865310
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3993
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077189.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865310
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865310 | COMPOSITION FOR STIMULATING NATURAL KILLER CELL ACTIVITY | Jan 29, 2009 | Abandoned |
Array
(
[id] => 7501497
[patent_doc_number] => 20110263504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE'
[patent_app_type] => utility
[patent_app_number] => 12/863973
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 49853
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263504.pdf
[firstpage_image] =>[orig_patent_app_number] => 12863973
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863973 | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | Jan 21, 2009 | Issued |
Array
(
[id] => 8063853
[patent_doc_number] => 20110245093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'FUNCTIONAL PROTEIN ARRAYS'
[patent_app_type] => utility
[patent_app_number] => 12/351465
[patent_app_country] => US
[patent_app_date] => 2009-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 8501
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245093.pdf
[firstpage_image] =>[orig_patent_app_number] => 12351465
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/351465 | FUNCTIONAL PROTEIN ARRAYS | Jan 8, 2009 | Abandoned |
Array
(
[id] => 6446351
[patent_doc_number] => 20100279952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'CROSS-LINKED HYDROGEL CONTAINING AN ACTIVE SUBSTANCE'
[patent_app_type] => utility
[patent_app_number] => 12/747435
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4318
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279952.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747435
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747435 | CROSS-LINKED HYDROGEL CONTAINING AN ACTIVE SUBSTANCE | Dec 21, 2008 | Abandoned |
Array
(
[id] => 6446158
[patent_doc_number] => 20100279934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'TOPICAL COMPOSITIONS FOR DELIVERY OF PROTEINS AND PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/810470
[patent_app_country] => US
[patent_app_date] => 2008-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12769
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0279/20100279934.pdf
[firstpage_image] =>[orig_patent_app_number] => 12810470
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/810470 | TOPICAL COMPOSITIONS FOR DELIVERY OF PROTEINS AND PEPTIDES | Dec 18, 2008 | Abandoned |
Array
(
[id] => 8870881
[patent_doc_number] => 08466258
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-18
[patent_title] => 'Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis'
[patent_app_type] => utility
[patent_app_number] => 12/746996
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12717
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12746996
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/746996 | Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis | Dec 10, 2008 | Issued |